We first determined the expression of CD133 on the human colon adenocarcinomas HT29 and WiDr, the human breast cancer cell lines MDA-MB-231 and MCF7, the human glioblastoma U87 and the murine embryonic fibroblasts NIH/3T3 by flow cytometry. This evidence concerns the gene PROM1 and glioblastoma.